Barclays
NUVA

Barclays’s NuVasive, Inc. NUVA Stock Holding History

Barclays’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-127,283
Closed -$5.29M – 4779
2023
Q2 		$5.29M Buy
127,283
+15,631
+14% +$642K ﹤0.01% 1318
2023
Q1 		$4.61M Buy
111,652
+24,103
+28% +$1.03M ﹤0.01% 1599
2022
Q4 		$3.61M Sell
87,549
-79,738
-48% -$3.23M ﹤0.01% 1854
2022
Q3 		$7.33M Sell
167,287
-724,464
-81% -$35.1M 0.01% 971
2022
Q2 		$43.8M Buy
891,751
+246,787
+38% +$13.2M 0.03% 434
2022
Q1 		$36.6M Sell
644,964
-504,673
-44% -$26.8M 0.03% 503
2021
Q4 		$60.3M Buy
1,149,637
+948,360
+471% +$51.5M 0.02% 512
2021
Q3 		$12M Buy
201,277
+2,397
+1% +$148K 0.01% 1093
2021
Q2 		$13.5M Sell
198,880
-4,874
-2% -$333K 0.01% 1072
2021
Q1 		$13.4M Buy
203,754
+47,057
+30% +$2.82M 0.01% 964
2020
Q4 		$8.83M Sell
156,697
-359,497
-70% -$17.7M ﹤0.01% 1216
2020
Q3 		$25.1M Buy
516,194
+390,503
+311% +$21M 0.01% 646
2020
Q2 		$7M Buy
125,691
+80,580
+179% +$4.66M 0.01% 1156
2020
Q1 		$2.28M Sell
45,111
-32,974
-42% -$2.21M ﹤0.01% 2170
2019
Q4 		$6.04M Buy
78,085
+31,569
+68% +$2.23M ﹤0.01% 1820
2019
Q3 		$2.95M Sell
46,516
-17,802
-28% -$1.11M ﹤0.01% 2401
2019
Q2 		$3.76M Buy
64,318
+13,470
+26% +$795K ﹤0.01% 2145
2019
Q1 		$2.89M Sell
50,848
-39,262
-44% -$2.09M ﹤0.01% 2172
2018
Q4 		$4.46M Buy
90,110
+44,404
+97% +$2.67M ﹤0.01% 1674
2018
Q3 		$3.24M Buy
45,706
+906
+2% +$57.6K ﹤0.01% 2303
2018
Q2 		$2.34M Buy
44,800
+5,481
+14% +$287K ﹤0.01% 2432
2018
Q1 		$2.05M Sell
39,319
-16,408
-29% -$832K ﹤0.01% 2432
2017
Q4 		$3.26M Sell
55,727
-61,614
-53% -$3.49M ﹤0.01% 1997
2017
Q3 		$6.51M Buy
117,341
+115,747
+7,261% +$7.66M 0.01% 1340
2017
Q2 		$123K Sell
1,594
-15,893
-91% -$1.19M ﹤0.01% 4765
2017
Q1 		$1.3M Sell
17,487
-20,259
-54% -$1.47M ﹤0.01% 2484
2016
Q4 		$2.54M Buy
37,746
+36,722
+3,586% +$2.37M ﹤0.01% 1928
2016
Q3 		$67K Sell
1,024
-7,282
-88% -$464K ﹤0.01% 4806
2016
Q2 		$496K Sell
8,306
-91,701
-92% -$4.96M ﹤0.01% 3224
2016
Q1 		$4.8M Buy
100,007
+79,331
+384% +$3.6M 0.01% 1208
2015
Q4 		$1.12M Buy
20,676
+13,224
+177% +$674K ﹤0.01% 2518
2015
Q3 		$358K Buy
7,452
+6,501
+684% +$336K ﹤0.01% 3655
2015
Q2 		$44K Sell
951
-547
-37% -$25.6K ﹤0.01% 5240
2015
Q1 		$68K Sell
1,498
-5,818
-80% -$270K ﹤0.01% 5092
2014
Q4 		$343K Sell
7,316
-15,690
-68% -$654K ﹤0.01% 4197
2014
Q3 		$782K Buy
23,006
+9,217
+67% +$328K ﹤0.01% 3580
2014
Q2 		$483K Sell
13,789
-2,539
-16% -$86.9K ﹤0.01% 4022
2014
Q1 		$621K Sell
16,328
-4,728
-22% -$174K ﹤0.01% 3734
2013
Q4 		$674K Sell
21,056
-3,013
-13% -$90.5K ﹤0.01% 3799
2013
Q3 		$578K Sell
24,069
-12,861
-35% -$316K ﹤0.01% 3954
2013
Q2 		$916K Buy
+36,930
New +$808K ﹤0.01% 3491

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Barclays's NUVA Position: Q3 2023 in Review

Barclays sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 127,283 shares — an estimated $5.29M sold.

Barclays first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $60.3M in Q4 2021. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Barclays reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Barclays sold 127,283 NuVasive, Inc. shares in Q3 2023, an estimated $5.29M.
  • Barclays first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • Barclays's NuVasive, Inc. position peaked at $60.3M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.